{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T23:26:43Z","timestamp":1783121203589,"version":"3.54.6"},"reference-count":33,"publisher":"MDPI AG","issue":"10","license":[{"start":{"date-parts":[[2022,10,2]],"date-time":"2022-10-02T00:00:00Z","timestamp":1664668800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Genes"],"abstract":"<jats:p>Thin basement membrane nephropathy (TBMN) is characterized by the observation of microhematuria and a thin glomerular basement membrane on kidney biopsy specimens. Its main cause is heterozygous mutations of COL4A3 or COL4A4, which also cause late-onset focal segmental glomerulosclerosis (FSGS) or autosomal dominant Alport syndrome (ADAS). Thirteen TBMN cases were analyzed using Sanger sequencing, multiplex ligation-dependent probe amplification (MLPA), and exome sequencing. Ten heterozygous variants were detected in COL4A3 or COL4A4 in nine patients via Sanger sequencing, three of which were novel variants. The diagnostic rate of \u201clikely pathogenic\u201d or \u201cpathogenic\u201d under the American College of Medical Genetics and Genomics guidelines was 53.8% (7 out of 13 patients). There were eight single nucleotide variants, seven of which were glycine substitutions in the collagenous domain, one of which was a splice-site single nucleotide variant, and two of which were deletion variants. One patient had digenic variants in COL4A3 and COL4A4. While MLPA analyses showed negative results, exome sequencing identified three heterozygous variants in causative genes of FSGS in four patients with no apparent variants on Sanger sequencing. Since patients with heterozygous mutations of COL4A3 or COL4A4 showed a wide spectrum of disease from TBMN to ADAS, careful follow-up will be necessary for these patients.<\/jats:p>","DOI":"10.3390\/genes13101779","type":"journal-article","created":{"date-parts":[[2022,10,8]],"date-time":"2022-10-08T20:43:21Z","timestamp":1665261801000},"page":"1779","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Mutation Analysis of Thin Basement Membrane Nephropathy"],"prefix":"10.3390","volume":"13","author":[{"given":"Yosuke","family":"Hirabayashi","sequence":"first","affiliation":[{"name":"Department of Cardiology and Nephrology, Mie University Graduate School of Medicine, Tsu 514-8507, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6663-133X","authenticated-orcid":false,"given":"Kan","family":"Katayama","sequence":"additional","affiliation":[{"name":"Department of Cardiology and Nephrology, Mie University Graduate School of Medicine, Tsu 514-8507, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mutsuki","family":"Mori","sequence":"additional","affiliation":[{"name":"Department of Cardiology and Nephrology, Mie University Graduate School of Medicine, Tsu 514-8507, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Matsuo","sequence":"additional","affiliation":[{"name":"Department of Cardiology and Nephrology, Mie University Graduate School of Medicine, Tsu 514-8507, Japan"},{"name":"Department of Kidney Center, Suzuka Kaisei Hospital, Suzuka 513-8505, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mika","family":"Fujimoto","sequence":"additional","affiliation":[{"name":"Department of Cardiology and Nephrology, Mie University Graduate School of Medicine, Tsu 514-8507, Japan"},{"name":"Department of Internal Medicine, Takeuchi Hospital, Tsu 514-0057, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9334-3664","authenticated-orcid":false,"given":"Kensuke","family":"Joh","sequence":"additional","affiliation":[{"name":"Department of Pathology, The Jikei University School of Medicine, Tokyo 105-0003, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomohiro","family":"Murata","sequence":"additional","affiliation":[{"name":"Department of Cardiology and Nephrology, Mie University Graduate School of Medicine, Tsu 514-8507, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaaki","family":"Ito","sequence":"additional","affiliation":[{"name":"Department of Cardiology and Nephrology, Mie University Graduate School of Medicine, Tsu 514-8507, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaoru","family":"Dohi","sequence":"additional","affiliation":[{"name":"Department of Cardiology and Nephrology, Mie University Graduate School of Medicine, Tsu 514-8507, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2022,10,2]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"2470","DOI":"10.1172\/JCI119431","article-title":"Isoform switching of type IV collagen is developmentally arrested in X-linked Alport syndrome leading to increased susceptibility of renal basement membranes to endoproteolysis","volume":"99","author":"Kalluri","year":"1997","journal-title":"J. Clin. Investig."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1093\/ckj\/sfz176","article-title":"Prevalence of clinical, pathological and molecular features of glomerular basement membrane nephropathy caused by COL4A3 or COL4A4 mutations: A systematic review","volume":"13","author":"Matthaiou","year":"2020","journal-title":"Clin. Kidney J."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1046\/j.1523-1755.2003.00234.x","article-title":"Thin basement membrane nephropathy","volume":"64","author":"Savige","year":"2003","journal-title":"Kidney Int."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.semnephrol.2005.01.004","article-title":"The clinical features of thin basement membrane nephropathy","volume":"25","author":"Gregory","year":"2005","journal-title":"Semin. Nephrol."},{"key":"ref_5","first-page":"453","article-title":"Glomerular basement membrane thickness in normal adults and its application to the diagnosis of thin basement membrane disease: An Indian study","volume":"48","author":"Rayat","year":"2005","journal-title":"Indian J. Pathol. Microbiol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1172\/JCI118893","article-title":"Benign familial hematuria due to mutation of the type IV collagen alpha4 gene","volume":"98","author":"Lemmink","year":"1996","journal-title":"J. Clin. Investig."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1681\/ASN.V1351248","article-title":"Mutations in theCOL4A4 and COL4A3 genes cause familial benign hematuria","volume":"13","author":"Badenas","year":"2002","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1111\/j.1523-1755.2004.00453.x","article-title":"COL4A3 mutations and their clinical consequences in thin basement membrane nephropathy (TBMN)","volume":"65","author":"Wang","year":"2004","journal-title":"Kidney Int."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1007\/s10157-018-1629-4","article-title":"A review of clinical characteristics and genetic backgrounds in Alport syndrome","volume":"23","author":"Nozu","year":"2019","journal-title":"Clin. Exp. Nephrol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1093\/ndt\/12.8.1595","article-title":"Autosomal dominant Alport syndrome linked to the type IV collage alpha 3 and alpha 4 genes (COL4A3 and COL4A4)","volume":"12","author":"Jefferson","year":"1997","journal-title":"Nephrol Dial. Transplant."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.1111\/j.1523-1755.2000.00358.x","article-title":"Autosomal dominant Alport syndrome caused by a COL4A3 splice site mutation","volume":"58","author":"Heidet","year":"2000","journal-title":"Kidney Int."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1111\/cge.12258","article-title":"Unbiased next generation sequencing analysis confirms the existence of autosomal dominant Alport syndrome in a relevant fraction of cases","volume":"86","author":"Fallerini","year":"2014","journal-title":"Clin. Genet."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"2740","DOI":"10.1681\/ASN.2013080912","article-title":"Improving mutation screening in familial hematuric nephropathies through next generation sequencing","volume":"25","author":"Dahan","year":"2014","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"502","DOI":"10.2215\/CJN.05960616","article-title":"Focal Segmental Glomerulosclerosis","volume":"12","author":"Rosenberg","year":"2017","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"3004","DOI":"10.1681\/ASN.2007040444","article-title":"COL4A3\/COL4A4 mutations producing focal segmental glomerulosclerosis and renal failure in thin basement membrane nephropathy","volume":"18","author":"Voskarides","year":"2007","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"2721","DOI":"10.1093\/ndt\/gfp158","article-title":"Clinico-pathological correlations in 127 patients in 11 large pedigrees, segregating one of three heterozygous mutations in the COL4A3\/ COL4A4 genes associated with familial haematuria and significant late progression to proteinuria and chronic kidney disease from focal segmental glomerulosclerosis","volume":"24","author":"Pierides","year":"2009","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1159\/000435789","article-title":"Carriers of Autosomal Recessive Alport Syndrome with Thin Basement Membrane Nephropathy Presenting as Focal Segmental Glomerulosclerosis in Later Life","volume":"130","author":"Deltas","year":"2015","journal-title":"Nephron."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1111\/cge.13077","article-title":"Frequent COL4 mutations in familial microhematuria accompanied by later-onset Alport nephropathy due to focal segmental glomerulosclerosis","volume":"92","author":"Papazachariou","year":"2017","journal-title":"Clin. Genet."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1093\/bioinformatics\/btm091","article-title":"Enhancements and modifications of primer design program Primer3","volume":"23","author":"Koressaar","year":"2007","journal-title":"Bioinformatics"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/gim.2015.30","article-title":"ACMG Laboratory Quality Assurance Committee. Standards and guidelines for the interpretation of sequence variants: A joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology","volume":"17","author":"Richards","year":"2015","journal-title":"Genet. Med."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1186\/s13059-017-1212-4","article-title":"The impact of rare and low-frequency genetic variants in common disease","volume":"18","author":"Bomba","year":"2017","journal-title":"Genome Biol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"D980","DOI":"10.1093\/nar\/gkt1113","article-title":"ClinVar: Public archive of relationships among sequence variation and human phenotype","volume":"42","author":"Landrum","year":"2014","journal-title":"Nucleic Acids Res."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1002\/humu.21438","article-title":"LOVD v.2.0: The next generation in gene variant databases","volume":"32","author":"Fokkema","year":"2011","journal-title":"Hum. Mutat."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/s00467-017-3838-6","article-title":"Genetic testing in steroid-resistant nephrotic syndrome: Why, who, when and how?","volume":"34","author":"Preston","year":"2019","journal-title":"Pediatr. Nephrol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1007\/s00467-011-2084-6","article-title":"Evidence that NPHS2-R229Q predisposes to proteinuria and renal failure in familial hematuria","volume":"27","author":"Voskarides","year":"2012","journal-title":"Pediatr. Nephrol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1111\/j.1399-0004.2012.01849.x","article-title":"Genotype-phenotype correlation in X-linked Alport syndrome patients carrying missense mutations in the collagenous domain of COL4A5","volume":"82","author":"Tsiakkis","year":"2012","journal-title":"Clin. Genet."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1038\/s41431-021-00858-1","article-title":"Consensus statement on standards and guidelines for the molecular diagnostics of Alport syndrome: Refining the ACMG criteria","volume":"29","author":"Savige","year":"2021","journal-title":"Eur. J. Hum. Genet."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.2215\/CJN.01000116","article-title":"Genetic, Clinical, and Pathologic Backgrounds of Patients with Autosomal Dominant Alport Syndrome","volume":"11","author":"Kamiyoshi","year":"2016","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1136\/jmedgenet-2014-102822","article-title":"Evidence of digenic inheritance in Alport syndrome","volume":"52","author":"Mencarelli","year":"2015","journal-title":"J. Med. Genet."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1038\/ki.2011.407","article-title":"Early angiotensin-converting enzyme inhibition in Alport syndrome delays renal failure and improves life expectancy","volume":"81","author":"Gross","year":"2012","journal-title":"Kidney Int."},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Mastrangelo, A., Madeira, C., Castorina, P., Giani, M., and Montini, G. (2021). Heterozygous COL4A3\/COL4A4 mutations: The hidden part of the iceberg?. Nephrol. Dial. Transplant., gfab334.","DOI":"10.1093\/ndt\/gfab334"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"628","DOI":"10.3389\/fgene.2019.00628","article-title":"A Nonsense Mutation in COL4A4 Gene Causing Isolated Hematuria in Either Heterozygous or Homozygous State","volume":"10","author":"Yang","year":"2019","journal-title":"Front. Genet."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1111\/nep.13115","article-title":"Autosomal dominant form of type IV collagen nephropathy exists among patients with hereditary nephritis difficult to diagnose clinicopathologically","volume":"23","author":"Imafuku","year":"2018","journal-title":"Nephrology"}],"container-title":["Genes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2073-4425\/13\/10\/1779\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T00:45:27Z","timestamp":1760143527000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2073-4425\/13\/10\/1779"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,2]]},"references-count":33,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2022,10]]}},"alternative-id":["genes13101779"],"URL":"https:\/\/doi.org\/10.3390\/genes13101779","relation":{},"ISSN":["2073-4425"],"issn-type":[{"value":"2073-4425","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,2]]}}}